Steris Plc (NYSE:STE) Director Mohsen Sohi sold 2,744 shares of the business’s stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $85.98, for a total transaction of $235,929.12. Following the transaction, the director now owns 21,816 shares of the company’s stock, valued at approximately $1,875,739.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Steris Plc (NYSE STE) traded up 0.35% during trading on Friday, reaching $84.94. 358,659 shares of the company’s stock traded hands. The stock has a 50-day moving average price of $82.49 and a 200 day moving average price of $74.96. Steris Plc has a 1-year low of $63.80 and a 1-year high of $87.49. The stock has a market capitalization of $7.24 billion, a P/E ratio of 60.76 and a beta of 1.33.

Steris Plc (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The business had revenue of $608 million during the quarter, compared to analyst estimates of $597.66 million. During the same period in the previous year, the business posted $0.79 EPS. The company’s quarterly revenue was down 4.8% on a year-over-year basis. Equities research analysts expect that Steris Plc will post $4.06 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th will be issued a $0.31 dividend. The ex-dividend date is Friday, August 25th. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a dividend yield of 1.46%. Steris Plc’s payout ratio is 80.00%.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/11/insider-selling-steris-plc-ste-director-sells-2744-shares-of-stock.html.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Teachers Advisors LLC raised its position in Steris Plc by 9.1% in the fourth quarter. Teachers Advisors LLC now owns 200,351 shares of the medical equipment provider’s stock valued at $13,502,000 after buying an additional 16,717 shares during the period. CENTRAL TRUST Co raised its position in Steris Plc by 1.3% in the first quarter. CENTRAL TRUST Co now owns 3,670 shares of the medical equipment provider’s stock valued at $255,000 after buying an additional 47 shares during the period. Raymond James Trust N.A. raised its position in Steris Plc by 1.3% in the first quarter. Raymond James Trust N.A. now owns 5,473 shares of the medical equipment provider’s stock valued at $380,000 after buying an additional 71 shares during the period. Private Trust Co. NA acquired a new position in Steris Plc during the first quarter valued at approximately $485,000. Finally, Louisiana State Employees Retirement System raised its position in Steris Plc by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 21,400 shares of the medical equipment provider’s stock valued at $1,486,000 after buying an additional 300 shares during the period. 91.80% of the stock is owned by institutional investors and hedge funds.

A number of equities analysts recently commented on STE shares. Zacks Investment Research upgraded shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a research note on Tuesday, July 11th. Wellington Shields downgraded shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. KeyCorp upgraded shares of Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price objective for the company in a research note on Wednesday, May 3rd. BidaskClub downgraded shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Finally, Raymond James Financial, Inc. upped their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Steris Plc currently has an average rating of “Buy” and a consensus price target of $86.75.

About Steris Plc

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Insider Buying and Selling by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.